• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有 H274Y 突变的禽流感 H5N1 病毒中奥司他韦耐药的来源。

Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation.

机构信息

Department of Chemistry, Faculty of Science, Chulalongkorn University, Patumwan, Bangkok, 10330, Thailand.

出版信息

Amino Acids. 2009 Oct;37(4):725-32. doi: 10.1007/s00726-008-0201-z. Epub 2008 Nov 12.

DOI:10.1007/s00726-008-0201-z
PMID:19002747
Abstract

Molecular dynamics simulations were carried out for the mutant oseltamivir-NA complex, to provide detailed information on the oseltamivir-resistance resulting from the H274Y mutation in neuraminidase (NA) of avian influenza H5N1 viruses. In contrast with a previous proposal, the H274Y mutation does not prevent E276 and R224 from forming the hydrophobic pocket for the oseltamivir bulky group. Instead, reduction of the hydrophobicity and size of pocket in the area around an ethyl moiety at this bulky group were found to be the source of the oseltamivir-resistance. These changes were primarily due to the dramatic rotation of the hydrophilic -COO(-) group of E276 toward the ethyl moiety. In addition, hydrogen-bonding interactions with N1 residues at the -NH(3) (+) and -NHAc groups of oseltamivir were replaced by a water molecule. The calculated binding affinity of oseltamivir to NA was significantly reduced from -14.6 kcal mol(-1) in the wild-type to -9.9 kcal mol(-1) in the mutant-type.

摘要

对突变奥司他韦-NA 复合物进行了分子动力学模拟,以提供有关流感病毒神经氨酸酶(NA)中 H274Y 突变导致奥司他韦耐药性的详细信息。与之前的提议相反,H274Y 突变并没有阻止 E276 和 R224 形成奥司他韦庞大基团的疏水口袋。相反,在该庞大基团的乙基部分周围区域的口袋的疏水性和大小的减少被发现是奥司他韦耐药性的来源。这些变化主要是由于亲水-COO(-)基团的 E276 向乙基部分的剧烈旋转引起的。此外,奥司他韦的-NH(3)(+)和-NHAc 基团的 N1 残基的氢键相互作用被一个水分子取代。奥司他韦与 NA 的计算结合亲和力从野生型的-14.6 kcal mol(-1)显著降低到突变型的-9.9 kcal mol(-1)。

相似文献

1
Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation.具有 H274Y 突变的禽流感 H5N1 病毒中奥司他韦耐药的来源。
Amino Acids. 2009 Oct;37(4):725-32. doi: 10.1007/s00726-008-0201-z. Epub 2008 Nov 12.
2
Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir.水分子渗透进入 H274Y 神经氨酸酶突变体的奥司他韦结合位点导致对奥司他韦的耐药性。
J Chem Inf Model. 2009 Dec;49(12):2735-41. doi: 10.1021/ci900348n.
3
How does each substituent functional group of oseltamivir lose its activity against virulent H5N1 influenza mutants?奥司他韦的每个取代基官能团是如何失去其对高致病性 H5N1 流感突变体的活性的?
Biophys Chem. 2009 Nov;145(1):29-36. doi: 10.1016/j.bpc.2009.08.006. Epub 2009 Aug 22.
4
Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.利用多维计算分析理解奥司他韦对甲型H1N1和H5N1流感神经氨酸酶突变的交叉耐药性。
Drug Des Devel Ther. 2015 Jul 31;9:4137-54. doi: 10.2147/DDDT.S81934. eCollection 2015.
5
Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)".关于《再探甲型H5N1流感病毒神经氨酸酶(NA)对奥司他韦(OTV)耐药性的分子机制》的评论
Biophys Chem. 2009 Apr;141(1):131-2; author reply 133. doi: 10.1016/j.bpc.2009.01.009. Epub 2009 Feb 2.
6
Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.长效神经氨酸酶抑制剂拉尼米韦对 H5N1 亚型和大流行 H1N1 流感病毒的结合模式。
J Mol Graph Model. 2012 Sep;38:148-54. doi: 10.1016/j.jmgm.2012.06.007. Epub 2012 Jul 4.
7
Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.探究奥司他韦(达菲)与2009年甲型H1N1流感病毒神经氨酸酶相互作用的见解。
Biochem Biophys Res Commun. 2009 Aug 28;386(3):432-6. doi: 10.1016/j.bbrc.2009.06.016. Epub 2009 Jun 10.
8
Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases.基于神经氨酸酶同源建模三维结构的甲型禽流感病毒(H5N1)耐药性研究
Biochem Biophys Res Commun. 2007 Mar 16;354(3):634-40. doi: 10.1016/j.bbrc.2006.12.235. Epub 2007 Jan 19.
9
Design of multi-binding-site inhibitors, ligand efficiency, and consensus screening of avian influenza H5N1 wild-type neuraminidase and of the oseltamivir-resistant H274Y variant.禽流感H5N1野生型神经氨酸酶及耐奥司他韦H274Y变体的多结合位点抑制剂设计、配体效率和一致性筛选
J Chem Inf Model. 2008 Oct;48(10):2074-80. doi: 10.1021/ci800242z. Epub 2008 Oct 11.
10
Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus.禽流感 H5N1 病毒神经氨酸酶奥司他韦耐药性的分子动力学模拟。
J Mol Model. 2011 Mar;17(3):587-92. doi: 10.1007/s00894-010-0757-x. Epub 2010 Jun 3.

引用本文的文献

1
Dynamic residue interaction network analysis of the oseltamivir binding site of N1 neuraminidase and its H274Y mutation site conferring drug resistance in influenza A virus.甲型流感病毒中N1神经氨酸酶的奥司他韦结合位点及其赋予耐药性的H274Y突变位点的动态残基相互作用网络分析
PeerJ. 2021 Jun 2;9:e11552. doi: 10.7717/peerj.11552. eCollection 2021.
2
Structural basis for potent inhibition of d-amino acid oxidase by thiophene carboxylic acids.噻吩羧酸类化合物强效抑制 D-氨基酸氧化酶的结构基础。
Eur J Med Chem. 2018 Nov 5;159:23-34. doi: 10.1016/j.ejmech.2018.09.040. Epub 2018 Sep 18.
3
Treating Influenza Infection, From Now and Into the Future.
治疗流感感染,从现在到未来。
Front Immunol. 2018 Sep 10;9:1946. doi: 10.3389/fimmu.2018.01946. eCollection 2018.
4
Hydrogen Bond Variations of Influenza A Viruses During Adaptation in Human.流感病毒在人类中适应过程中的氢键变化
Sci Rep. 2017 Oct 30;7(1):14295. doi: 10.1038/s41598-017-14533-3.
5
Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains.鉴定抗 H274Y/I222R 双突变株的神经氨酸酶抑制剂。
Sci Rep. 2017 Sep 26;7(1):12336. doi: 10.1038/s41598-017-12101-3.
6
Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.利用多维计算分析理解奥司他韦对甲型H1N1和H5N1流感神经氨酸酶突变的交叉耐药性。
Drug Des Devel Ther. 2015 Jul 31;9:4137-54. doi: 10.2147/DDDT.S81934. eCollection 2015.
7
A 3D-RISM/RISM study of the oseltamivir binding efficiency with the wild-type and resistance-associated mutant forms of the viral influenza B neuraminidase.对奥司他韦与乙型流感病毒神经氨酸酶野生型及耐药相关突变体形式的结合效率进行的3D-RISM/RISM研究。
Protein Sci. 2016 Jan;25(1):147-58. doi: 10.1002/pro.2718. Epub 2015 Jun 22.
8
Discover binding pathways using the sliding binding-box docking approach: application to binding pathways of oseltamivir to avian influenza H5N1 neuraminidase.利用滑动结合盒对接方法发现结合途径:奥司他韦与禽流感 H5N1 神经氨酸酶结合途径的应用。
J Comput Aided Mol Des. 2013 Aug;27(8):689-95. doi: 10.1007/s10822-013-9675-1. Epub 2013 Aug 24.
9
An overview of the highly pathogenic H5N1 influenza virus.高致病性 H5N1 流感病毒概述。
Virol Sin. 2013 Feb;28(1):3-15. doi: 10.1007/s12250-013-3294-9. Epub 2013 Jan 16.
10
Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.I117V 取代介导的神经氨酸酶亚型 H5N1 禽流感 A 病毒奥司他韦耐药的分子机制。
J Infect Dis. 2013 Jan 1;207(1):89-97. doi: 10.1093/infdis/jis633. Epub 2012 Oct 10.